Selected article for: "acute ards respiratory distress syndrome develop and lung injury"

Author: Lupu, Ludmila; Palmer, Annette; Huber-Lang, Markus
Title: Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS
  • Cord-id: afb3skz4
  • Document date: 2020_9_25
  • ID: afb3skz4
    Snippet: Physical trauma can be considered an unrecognized “pandemic” because it can occur anywhere and affect anyone and represents a global burden. Following severe tissue trauma, patients frequently develop acute lung injury (ALI) and/or acute respiratory distress syndrome (ARDS) despite modern surgical and intensive care concepts. The underlying complex pathophysiology of life-threatening ALI/ARDS has been intensively studied in experimental and clinical settings. However, currently, the coronavi
    Document: Physical trauma can be considered an unrecognized “pandemic” because it can occur anywhere and affect anyone and represents a global burden. Following severe tissue trauma, patients frequently develop acute lung injury (ALI) and/or acute respiratory distress syndrome (ARDS) despite modern surgical and intensive care concepts. The underlying complex pathophysiology of life-threatening ALI/ARDS has been intensively studied in experimental and clinical settings. However, currently, the coronavirus family has become the focus of ALI/ARDS research because it represents an emerging global public health threat. The clinical presentation of the infection is highly heterogeneous, varying from a lack of symptoms to multiple organ dysfunction and mortality. In a particular subset of patients, the primary infection progresses rapidly to ALI and ARDS. The pathophysiological mechanisms triggering and driving severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-induced ALI/ARDS are still poorly understood. Although it is also generally unknown whether insights from trauma-induced ARDS may be readily translated to SARS-CoV-2-associated ARDS, it was still recommended to treat coronavirus-positive patients with ALI/ARDS with standard protocols for ALI/ARDS. However, this strategy was questioned by clinical scientists, because it was documented that some severely hypoxic SARS-CoV-2-infected patients exhibited a normal respiratory system compliance, a phenomenon rarely observed in ARDS patients with another underlying etiology. Therefore, coronavirus-induced ARDS was defined as a specific ARDS phenotype, which accordingly requires an adjusted therapeutic approach. These suggestions reflect previous attempts of classifying ARDS into different phenotypes that might overall facilitate ARDS diagnosis and treatment. Based on the clinical data from ARDS patients, two major phenotypes have been proposed: hyper- and hypo-inflammatory. Here, we provide a comparative review of the pathophysiological pathway of trauma-/hemorrhagic shock-induced ARDS and coronavirus-induced ARDS, with an emphasis on the crucial key points in the pathogenesis of both these ARDS forms. Therefore, the manifold available data on trauma-/hemorrhagic shock-induced ARDS may help to better understand coronavirus-induced ARDS.

    Search related documents:
    Co phrase search for related documents
    • absolute neutrophil count and acute ards respiratory distress syndrome: 1, 2
    • absolute neutrophil count and acute pancreatitis: 1
    • acid exposure and activation status: 1
    • acid exposure and acute lung injury: 1
    • activate neutrophil and acute ards respiratory distress syndrome: 1
    • activate neutrophil and acute lung injury: 1
    • activation process and acute ards respiratory distress syndrome: 1
    • activation status and acute ards respiratory distress syndrome: 1
    • activation status and acute lung injury: 1, 2
    • activation status and acute onset: 1
    • active transport and acute lung injury: 1, 2, 3, 4, 5
    • acute ards respiratory distress syndrome and ade antibody dependent enhancement: 1, 2
    • acute ards respiratory distress syndrome and adhesion molecule: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and local inflammatory response: 1, 2, 3, 4
    • acute ards respiratory distress syndrome and low amount: 1
    • acute lung injury and ade antibody dependent enhancement: 1
    • acute lung injury and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8
    • acute lung injury and local inflammatory response: 1, 2, 3
    • acute onset and adhesion molecule: 1